Search

The objective of this study was to evaluate the impact of dietary zinc supplementation in pre-weaned dairy calves on the phenotypic antimicrobial resistance (AMR) of fecal commensal bacteria. A repository of fecal specimens from a random sample of calves block-randomized into placebo (n = 39) and zinc sulfate (n = 28) groups collected over a zinc supplementation clinical trial at the onset of calf diarrhea, calf diarrheal cure, and the last day of 14 cumulative days of zinc or placebo treatment were analyzed. Antimicrobial susceptibility testing was conducted for Enterococcus spp. (n = 167) and E. coli (n = 44), with one representative isolate of each commensal bacteria tested per sample. Parametric survival interval regression models were constructed to evaluate the association between zinc treatment and phenotypic AMR, with exponentiated accelerated failure time (AFT) coefficients adapted for MIC instead of time representing the degree of change in AMR (MIC Ratio, MR). Findings from our study indicated that zinc supplementation did not significantly alter the MIC in Enterococcus spp. for 13 drugs: gentamicin, vancomycin, ciprofloxacin, erythromycin, penicillin, nitrofurantoin, linezolid, quinupristin/dalfopristin, tylosin tartrate, streptomycin, daptomycin, chloramphenicol, and tigecycline (MR = 0.96-2.94, p > 0.05). In E. coli, zinc supplementation was not associated with resistance to azithromycin (MR = 0.80, p > 0.05) and ceftriaxone (MR = 0.95, p > 0.05). However, a significant reduction in E. coli MIC values was observed for ciprofloxacin (MR = 0.17, 95% CI 0.03-0.97) and nalidixic acid (MR = 0.28, 95% CI 0.15-0.53) for zinc-treated compared to placebo-treated calves. Alongside predictions of MIC values generated from these 17 AFT models, findings from this study corroborate the influence of age and antimicrobial exposure on phenotypic AMR.

The increase in life expectancy has led to a concerning decline in the body's functional capacity, particularly in bone health, where decreased resistance and increased fracture susceptibility pose significant challenges in orthopedics. While traditional bone grafting methods have drawbacks, synthetic materials, particularly hydroxyapatite (HA), offer promising alternatives due to their biocompatibility and osteoconductive properties. However, HA's mechanical limitations necessitate reinforcement, with boron nitride nanostructures emerging as a particularly effective option, enhancing fracture resistance and combining HA with collagen, further mimicking natural bone composition, offering several benefits. Moreover, crosslinking agents like tannic acid (TA) improve collagen's stability and introduce therapeutic benefits. Therefore, the present work aimed to synthesize an innovative nanocomposite formed by hydroxyapatite, boron nitride nanostructures, collagen, and tannic acid. The nanocomposites obtained were characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), thermogravimetry (TGA), elemental analysis of carbon, hydrogen, and nitrogen (CHN), and scanning electron microscopy (SEM). Mechanical tests of Vickers hardness, nanoindentation, tensile, and DMA demonstrated an increase in the mechanical resistance of the nanocomposites, thus corroborating their promising character. A controlled drug release test showed that the system could be used for antibiotic (ciprofloxacin) delivery, further expanding its function. Biological cell viability assays reported that the system is not toxic to healthy cells and is harmful to tumor cells, thus demonstrating the antitumor nature of TA. Therefore, integrating HA, BN nanostructures, collagen, and TA into a multifunctional nanocomposite, a novel approach in orthopedic biomaterial design is offered as a promising solution to address various bone-related challenges. [ABSTRACT FROM AUTHOR]

Well-dispersed MIL-100(Fe) nanoparticles were synthesized under mild conditions and used to construct a photo-Fenton system (VMH system) with the assistance of visible-light irradiation and hydrogen peroxide. In such a VMH system, the MIL-100(Fe) has a high specific surface area and provides numerous Fe3+ active sites, thus accelerating the reaction of Fe3+ with photo-generated electrons under visible-light irradiation and generates Fe2+, and then the acquired Fe2+ can activate H2O2 to generate ⋅OH, accompanying with the oxidation of Fe2+ to Fe3+. Hence, the in-situ recycling of Fe2+/Fe3+ promotes the generation of ·OH, thus making the VMH system exhibits promising photocatalytic activity. The removal rate of ciprofloxacin in the VMH system is as high as 95.2% within 120 min photo-Fenton reaction, which is about 26 times higher than that of the Visible light/MIL-100(Fe) system. Moreover, the VMH system also exhibits strong degradation ability to other typical antibiotics, such as tetracycline, norfloxacin and cephalexin, and maintains high cyclic stability, revealing great practical application potential in the purification of antibiotic wastewater. [ABSTRACT FROM AUTHOR]

Antibiotics have several negative effects on aquatic ecosystems and are difficult to degrade using traditional water/wastewater treatment methods. As a result, new treatment techniques must be employed to eliminate these contaminants from aquatic environments. Research on the relationship between the decomposing process of antibiotics and different factors by new technologies is scarce. This research focuses on the capability of ozone micro-nano bubbles (OzMNBs) to eliminate the antibiotics ciprofloxacin (CIPR) and levofloxacin (LEVO) in aqueous solutions. We studied the CIPR and LEVO decomposition to different variables through the central composite design method. The main variables included pH, ozonation time, and initial antibiotic concentration. The correlation coefficients of the quadratic model obtained by using the software, Design Expert version 13.0.1. Analysis of variances proved the significance of models and main factors. Verification tests also confirmed that the final optimum conditions of the antibiotics decomposition were: pH 9, ozonation for 40 min and, initial antibiotic concentration of 5 mg/L. In optimum conditions, removal rate of about 97% and 100% was obtained for CIPR and LEVO, respectively. The order of influence of various factors on CIPR and LEVO decomposition were obtained and the interactions between the main factors were also investigated. At the last stage of the research, the efficiency of OzMNBs in the removal of total organic carbon and mineralization of the solutions containing CIPR and LEVO under optimum conditions was examined. [ABSTRACT FROM AUTHOR]

ABSTRACT The biogenic synthesis of silver nanoparticles (AgNPs) with leaf extract Abution indicum was done, and those were characterized by ultraviolet–visible spectroscopy (UV–vis), Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), powder X‐ray diffraction (PXRD), field emission scanning electron microscopy (FESEM) and transmission electron microscope (TEM) with energy‐dispersive X‐ray (EDX) spectroscopy. The analysis by UV–vis spectroscopy showed a peak of 450 nm, and DLS and zeta potential were utilized to determine the size distribution of the biosynthesized Abution indicum–AgNPs (AI‐AgNPs) with a size range of 24–37 nm, and the X‐ray diffraction peak 38.096o was used to confirm that the crystalline structure of AI‐AgNPs. Furthermore, the antipathogenic effect of synthesized AgNPs and standard antibiotic (Ciprofloxacin) as studied the positive control in different types of bacterial pathogens likes Staphylococcus aureus and Escherichia Coli, with the zone of inhibition values of 9 mm. The synthesized AgNPs displayed excellent photocatalytic activity against reactive blue under sunlight than a UV light irradiation, and maximum degradation of 43% was achieved with 66 min of reaction time. In view of promising activity, the AgNPs could be used photocatalyst for the degradation of dyes in wastewater, and pomegranate leaf extract can be applied as eco‐benign and cost‐effective approach for AgNPs synthesis. Hence, the current findings suggest that Abutilon indicum is a valuable source for tailoring the potential of AgNPs toward various enhanced biological, photocatalytic, and adsorption activities. Consequently, the plant biological molecule‐mediated synthesized AI‐AgNPs could be excellent contenders for future therapeutic applications. [ABSTRACT FROM AUTHOR]

The purpose of the present study was to create resorbable nanoparticles (NPs) using poly(lactic-co-glycolic acid) (PLGA) to develop novel antibacterial therapeutics for the treatment of chronic wound infections that are susceptible to recurrent infections. By first performing a release study, it was possible to predict the behavior of the different PLGA NP formulations and assess the efficacy of the nanocomposite drug delivery system. These PLGA NP formulations consisted of varying ratios of PLGA without polyvinyl alcohol (PVA) and PLGA with PVA (PLGA-PVA) (i.e. 25:75[PLGA25], 50:50[PLGA50], and 75:25[PLGA75]). Then, different antibiotics (i.e. ciprofloxacin and gentamicin) were incorporated into the PLGA NP formulations to test the antibacterial efficacy of these antimicrobial NPs against different pathogens (i.e. methicillin-resistant Staphylococcus aureus USA300 [MRSA], Pseudomonas aeruginosa FRD1, and Acinetobacter baumannii BAA1605). Of particular interest was testing against the MRSA strain USA300 and the P. aeruginosa strain FRD1. This was possible by measuring the zone of inhibition. A 3-day period was used to monitor the antibacterial efficacy of the different PLGA NP formulations (i.e. PLGA25, PLGA50, and a 1:1 combination of PLGA25:PLGA50) against A. baumannii BAA1605 , MRSA, and P aeruginosa FRD1. Throughout the study, A. baumannii was a negative control and was resistant to all the PLGA NP formulations loaded with ciprofloxacin and gentamicin. At the end of the 3-day period, the PLGA and PLGA50 ciprofloxacin-loaded formulations produced zones of inhibition of 27 mm and 23 mm, respectively, against P. aeruginosa FRD1. This indicated that P. aeruginosa FRD1 was susceptible to both formulations. The mixed formulations with equal parts PLGA25:PLGA50 loaded with ciprofloxacin produced a zone of inhibition (i.e. 25 mm). This again indicated that P. aeruginosa FRD1 was susceptible to ciprofloxacin. The formulations tested against MRSA showed that only gentamicin-loaded formulations produced intermediate results, and that ciprofloxacin-loaded formulations were ineffective. The PLGA25 and the PLGA50 NP formulations loaded with gentamicin both produced zones of inhibition of 13 mm. This indicated that MRSA was intermediate to both the formulations. The PLGA25:PLGA50 loaded with gentamicin produced a zone of inhibition of 14 mm, which again showed that MRSA was intermediate to this formulation. Overall, these PLGA NP formulations showed the sustained antibacterial potential of a burst release, followed by a sustained release of antibiotics from antibiotics loaded PLGA NPs in a controlled manner. In the future, this can help prevent the emergence of recurrent infections in the treatment of chronic wounds and reduce the number of medical dressing changes. [ABSTRACT FROM AUTHOR]

In the present study, the MnO2 adsorbents with a crystal structure, the components of approximately 59% Mn and 40% O, and the specific linkages of -OH and O-Mn-O were characterized by the techniques XDR, EDX, and FI-IR, respectively. Especially, the individual and simultaneous adsorptions of chromium, Cr(VI), and an antibiotic, CFX, on the manganese dioxide (MnO2) material were systematically investigated. Compared with the individual adsorption, the CFX adsorption efficiency was significantly reduced in the Cr(VI) presence due to the Cr(VI)-CFX complexation formed by the Cr2O72− or HCrO4−-NH2+ electrostatic attractions. The optimal experimental conditions for the Cr(VI)-CFX simultaneous adsorption were found to be pH 6, 1 mM NaCl, 60 min contact time, and 50 mg.mL−1 MnO2 dosage. The maximum adsorption efficiencies of the Cr(VI) and the CFX on the MnO2 were achieved at 98.1 and 87.5%, respectively. The maximum adsorption capacities of the Cr(VI) and CFX were correspondingly extrapolated to be 144.5 and 100.1 mg.g−1 by the Langmuir adsorption model. The Cr(VI)-CFX simultaneous adsorption was adequately described by the Freundlich isotherm and the pseudo-second kinetic models. The chemisorption of Cr(VI)-CFX governed the simultaneous adsorption with the formation of multiple adsorbed layers. [ABSTRACT FROM AUTHOR]

• Iron addition raised the removal efficiency of ciprofloxacin from 65 to 94%. • Electro-activated persulfate (EAP) with iron addition process is cost-effective. • EAP+Fe process is superior to EAP for ciprofloxacin removal. • Three ciprofloxacin intermediates were reported for the first time in this study. Ciprofloxacin (CIP) is a commonly used antibiotic in the fluoroquinolone group and is widely used in medical and veterinary medicine disciplines to treat bacterial infections. When CIP is discharged into the sewage system, it cannot be removed by a conventional wastewater treatment plant because of its recalcitrant characteristics. In this study, boron-doped diamond anode and persulfate were used to degrade CIP in an aquatic solution by creating an electrochemically activated persulfate (EAP) process. Iron was added to the system as a coactivator and the process was called EAP+Fe. The effects of independent variables, including pH, Fe2+, persulfate concentration, and electrolysis time on the system were optimized using the response surface methodology. The results showed that the EAP+Fe process removed 94% of CIP under the following optimum conditions: A pH of 3, persulfate/Fe2+ concentration of 0.4 mmol/L, initial CIP concentration 30 mg/L, and electrolysis time of 12.64 min. CIP removal efficiency was increased from 65.10% to 94.35% by adding Fe2+ as a transition metal. CIP degradation products, 7 pathways, and 78 intermediates of CIP were studied, and three of those intermediates (m/z 298, 498, and 505) were reported. The toxicological analysis based on toxicity estimation software results indicated that some degradation products of CIP were toxic to targeted animals, including fathead minnow, Daphnia magna, Tetrahymena pyriformis , and rats. The optimum operation costs were similar in EAP and EAP+Fe processes, approximately 0.54 €/m3. [Display omitted] [ABSTRACT FROM AUTHOR]

The present study is to develop and evaluate an ethosomal gel formulation of ciprofloxacin. It aims to provide a topical treatment for many bacterial infections that affect the skin. Administration of medications topically having the facility of delivering a high concentration of the drug to the skin than would be possible with systemic therapy. Topical administration of drugs is better for local action and the efficiency of the topically administered drug is increased with liposome, proliposomes and ethosomes. Recently, it was found that ethosomal carriers were phospholipid vesicular systems having relatively high concentrations of alcohol, enhances dermal and transdermal delivery of both lipophilic as well as hydrophilic molecules. Ciprofloxacin hydrochloride is a second-generation antibiotic and a BCS class II drug. Ethosomes were formulated using phospholipid, cholesterol, ethanol, polyethylene glycol and purified water by cold method. Ethosomes were evaluated for vesicle size, shape, optical microscopy, entrapment efficiency and in-vitro release study. F4 have better drug entrapment efficiency than the other formulation. The best formulation (F4) was used to prepare gel by using carbopol 934 as a gelling agent. The ethosomes were entrapped in gel matrix of carbopol 980 in different concentration 0.5%, 1.00% and 2% w/w. FT-IR studies revealed no interaction between the drug and excipients. The formulated gel formulation was evaluated with parameter pH, viscosity, spreadability, in-vitro release test, wash ability, extrudability study and stability studies. The formulation EGF2 have better in-vitro drug release profile which contains carbopol 980 concentration 1%w/w. the stability studies performed (EGF2) at refrigeration temperature (4.0±0.2°C), at room temperature (25-28±2°C) and 45±1°C for 45days. These ethosomes were unstable at higher temperature like 45.2°C. Percent efficiency of ethosomes also decrease at higher temperature like 4502°C. The present work also focuses on making the formulation more pharmaceutically acceptable. [ABSTRACT FROM AUTHOR]

Recent studies have explored the influence of obesity and critical illness on ciprofloxacin pharmacokinetics. However, variation across the subpopulation of individuals with obesity admitted to the intensive care unit (ICU) with varying renal function remains unexamined. This study aims to characterize ciprofloxacin pharmacokinetics in ICU patients with obesity and provide dose recommendations for this special population. Individual patient data of 34 ICU patients with obesity (BMI >30 kg/m2) from four studies evaluating ciprofloxacin pharmacokinetics in ICU patients were pooled and combined with data from a study involving 10 individuals with obesity undergoing bariatric surgery. All samples were collected after intravenous administration. Non‐linear mixed effects modeling and simulation were used to develop a population pharmacokinetic model and describe ciprofloxacin exposure in plasma. Model‐based dose evaluations were performed using a pharmacokinetic/pharmacodynamic target of AUC/MIC >125. The data from patients with BMI ranging from 30.2 to 58.1 were best described by a two‐compartment model with first‐order elimination and a proportional error model. The inclusion of Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) as a covariate on clearance reduced inter‐individual variability from 57.3% to 38.5% (P <.001). Neither body weight nor ICU admission significantly influenced clearance or volume of distribution. Renal function is a viable predictor for ciprofloxacin clearance in ICU patients with obesity, while critical illness and body weight do not significantly alter clearance. As such, body weight and critical illness do not need to be accounted for when dosing ciprofloxacin in ICU patients with obesity. Individuals with CKD‐EPI >60 mL/min/1.73 m2 may require higher dosages for the treatment of pathogens with minimal inhibitory concentration ≥0.25 mg/L. [ABSTRACT FROM AUTHOR]

Cu-doped Bi4O5Br2 photocatalyst was synthesized via a solvothermal method, and the influence of Cu doping on its structure, morphology, and photoelectric characteristics was comprehensively investigated by adopting various characterization techniques. Furthermore, the photocatalytic performance of the material was assessed through the degradation of ciprofloxacin (CIP) under visible light. The characterization results demonstrated that compared to the intrinsic Bi4O5Br2, the introduction of Cu resulted in a decreased bandgap, an expanded visible light absorption range, an enhanced visible light absorption intensity, and improved separation efficiency of electrons and holes, thereby enhancing the photocatalytic activity. In the ciprofloxacin degradation experiment, 3%Cu-Bi4O5Br2 exhibited superior performance, achieving a degradation rate of 80.1%, which was more than twice as high as the intrinsic Bi4O5Br2 (53.2%). Moreover, it maintained excellent stability even after undergoing five cycling experiments. The free radical capture experiments indicated that h+, •O2− and •OH played a dominant role in the photodegradation reactions of ciprofloxacin. Finally, this study discussed the possible photocatalytic mechanism and deduced three degradation pathways of ciprofloxacin on the basis of the 8 intermediate products detected by LCMS. In summary, Cu-Bi4O5Br2 demonstrated remarkable photocatalytic performance and stability under visible light response, positioning it as a promising catalyst for future sunlight-based removal of diverse pollutants. The doping of Cu enhances the absorption of visible light by Bi4O5Br2, improving its photocatalytic performance. The photocatalytic degradation mechanism of Cu-doped Bi4O5Br2 photocatalyst mainly includes three approaches. The holes can interact with electrons in ciprofloxacin (CIP), thereby directly oxidizing it. Next, photogenerated electrons combine with dissolved oxygen to form superoxide negative ions, and some of these are further oxidized to produce hydroxyl radicals. Both superoxide negative ions and hydroxyl radicals participate in the degradation of CIP. Last, Cu2+ captures photogenerated electrons and transforms into Cu+, which promotes the reduction of dissolved oxygen molecules to generate superoxide radicals (•O2-), accelerating the degradation of CIP. Meanwhile, Cu+ can be oxidized back to Cu2+. This conversion is dynamic and continuously cycles as long as the illumination persists [ABSTRACT FROM AUTHOR]

Ciprofloxacin (CIPH) was classified as one of the most effective quinolone antibiotics, which is commonly used to cure a wide range of infections resulting from Gram-negative and Gram-positive microorganisms. The complexes which formed due to the interaction of Ni(II), Zn(II), Cu(II), Gd(III) and Sm(III) with ciprofloxacin were characterized by CHN% analysis, conductivity, FTIR, electronic spectra, fluorescence measurements, and magnetic susceptibility, besides studying the complex–DNA interaction. Meanwhile, the molar conductance values (0.001 mol·L−1 in DMSO) revealed the electrolytic behavior of the complexes and could be designated with the A−B+ formula. In addition, the geometry of the compounds was confirmed from the electronic transitions as well as the μeff values as octahedral for all complexes. The postulated formula could be generally assigned as [M(CIP)a(CIPH)b(H2O)c](NO3)(H2O)n(C2H5OH)m. Moreover, the interaction between metal complexes and DNA revealed that the Cu complex had the highest binding constant. Nanotechnology was applied to synthesized compounds using silica nanoparticles (SiNPs), which were prepared using a sol–gel process. The silica nanoparticles were chemically functionalized for binding the ligand and its metal complexes; this enables the as-prepared compounds to enhance their features as a drug delivery platform. Meanwhile, the antimicrobial activity was tested for the free complexes and SiNPs composites. Collectively, Sm complex gave the largest zone of inhibition, while the Cu(II)–SiNPs composite showed the strongest potential to reduce the bacterial activity. Furthermore, the fluorescence data of CIPH, ligand–metal mixture and the effect of silica nanoparticles on them were studied. [ABSTRACT FROM AUTHOR]

Objectives: Previously, we developed a novel double‐coated sinus stent containing ciprofloxacin (inner layer) and azithromycin (outer layer) (CASS), but released drug concentrations were found to be insufficient for clinical usage. Our objectives are to improve drug release of CASS and assess safety and pharmacokinetics in rabbits. Methods: Dip coating was used to create the CASS with 2 mg ciprofloxacin and 5 mg azithromycin. A uniformed double coating was assessed with scanning electron microscopy (SEM), and the release patterns of both drugs and lactate dehydrogenase (LDH) assay were evaluated over 14 days in vitro. Safety, tolerability, and pharmacokinetics of the CASS were tested in rabbits through insertion into the maxillary sinus and evaluated with nasal endoscopy, CT scans, histology, blood counts and chemistries, and in vivo drug release. Results: SEM confirmed the uniformity of the dual coating of ciprofloxacin and azithromycin, and thickness (μm) was found to be 14.7 ± 2.4 and 28.1 ± 4.6, respectively. The inner coated ciprofloxacin showed a sustained release over 14 days (release %) when soaked in saline solution (day 7, 86.2 ± 3.4 vs. day 14,99.2 ± 5.1). In vivo analysis showed that after 12 days, 78.92 ± 7.67% of CP and 84.12 ± 0.45% of AZ were released into the sinus. There were no significant differences in body weight, white blood cell counts, and radiographic changes before and after CASS placement. No significant histological changes were observed compared to the contralateral control side. Conclusion: Findings suggest that the CASS is an effective method for delivering therapeutic levels of antibiotics. Further studies are needed to validate efficacy in a preclinical sinusitis model. Level of Evidence: N/A Laryngoscope, 134:3953–3959, 2024 [ABSTRACT FROM AUTHOR]

Concerns related to environmental risks associated with pharmaceuticals and personal care products (PPCPs) have led researchers to seek methods for assessing and monitoring these contaminants in the aquatic environment. Identifying and validating risk assessment tools that can evaluate ecological concerns and risks associated with PPCPs is critical. Herein, the suitability of a dose-related risk and effect assessment model, which estimates predicted environmental concentrations and allowed comparisons with predicted no effect concentrations determined, in combination with in vitro analyses of the whole effluent toxicity, was verified for the characterization of a PPCP hazard. Concentrations of the most utilized PPCPs in Norway were measured in influent and effluent samples and used to parameterize the fate model. Greater than 90% removal was attained for 12 out of 22 detected PPCPs. Removal was not dependent on the class or the concentration of the specific substance and varied between 12% and 100%. The PPCPs detected in the discharged wastewater were utilized to assess individual contributions to the risk of the effluent, and no risk was identified for the targeted 30 PPCP. The simulations provided valuable information regarding the discharge plume distribution over time, which can aid planning of future environmental monitoring investigations. Bioassays (using fish liver cells, PLHC-1) were used for assessing overall effluent toxicity, through cell viability, production of reactive oxygen species, and ethoxyresorufin-O-deethylase (EROD) activities. The present study may allow regulators to use risk-based strategies over removal criteria for monitoring studies and confirms the importance to take PPCP contamination into consideration when establishing environmental regulations. [ABSTRACT FROM AUTHOR]

Aortic aneurysm and dissection (AAD) is a cardiovascular disease that poses a severe threat to life and has high morbidity and mortality rates. Clinical and animal-based studies have irrefutably shown that fluoroquinolones, a commonly prescribed antibiotic for treating infections, significantly increase the risk of AAD. Despite this, the precise mechanism by which fluoroquinolones cause AAD remains unclear. Therefore, this study aims to investigate the molecular mechanism and role of Ciprofloxacin definitively—a type of fluoroquinolone antibiotic—in the progression of AAD. Aortic transcriptome data were collected from GEO datasets to detect the genes and pathways expressed differently between healthy donors and AAD patients. Human primary Vascular Smooth Muscle Cells (VSMCs) were isolated from the aorta. After 72 h of exposure to 110ug/ml Ciprofloxacin or 100 nmol/L AngII, either or combined, the senescent cells were identified through SA-β-gal staining. MitoTracker staining was used to examine the morphology of mitochondria in each group. Cellular Reactive Oxygen Species (ROS) levels were measured using MitoSox and DCFH-DA staining. Western blot assay was performed to detect the protein expression level. We conducted an analysis of transcriptome data from both healthy donors and patients with AAD and found that there were significant changes in cellular senescence-related signaling pathways in the latter group. We then isolated and identified human primary VSMCs from healthy donors (control-VSMCs) and patients' (AAD-VSMCs) aortic tissue, respectively. We found that VSMCs from patients exhibited senescent phenotype as compared to control-VSMCs. The higher levels of p21 and p16 and elevated SA-β-gal activity demonstrated this. We also found that pretreatment with Ciprofloxacin promoted angiotensin-II-induced cellular senescence in control-VSMCs. This was evidenced by increased SA-β-gal activity, decreased cell proliferation, and elevation of p21 and p16 protein levels. Additionally, we found that Angiotensin-II (AngII) induced VSMC senescence by promoting ROS generation. We used DCFH-DA and mitoSOX staining to identify that Ciprofloxacin and AngII pretreatment further elevated ROS levels than the vehicle or alone group. Furthermore, JC-1 staining showed that mitochondrial membrane potential significantly declined in the Ciprofloxacin and AngII combination group compared to others. Compared to the other three groups, pretreatment of Ciprofloxacin plus AngII could further induce mitochondrial fission, demonstrated by mitoTracker staining and western blotting assay. Mechanistically, we found that Ciprofloxacin impaired the balance of mitochondrial fission and fusion dynamics in VSMCs by suppressing the phosphorylation of AMPK signaling. This caused mitochondrial dysfunction and ROS generation, thereby elevating AngII-induced cellular senescence. However, treatment with the AMPK activator partially alleviated those effects. Our data indicate that Ciprofloxacin may accelerate AngII-induced VSMC senescence through modulating AMPK/ROS signaling and, subsequently, hasten the progression of AAD. [ABSTRACT FROM AUTHOR]

AbstractCiprofloxacin is used for curing infectious diseases and its residue pollutes the biosphere. We prepared coal-based activated carbon and characterized it by FTIR, SEM, BET, zeta potential, TGA and XRD. Its surface area is (3472 m2 g−1), pore volume (1.568 cm3 g−1) and pore size (1.808 nm) and disordered graphitic nature. The material removed ∼100% ciprofloxacin from aqueous solutions in 35 min. The adsorption data follows Langmuir, Freundlich, D-R and Temkin isotherms and a pseudo second-order kinetic model. The adsorption capacity of the material computed is 724.3 ± 23.5 mg g−1. Thermodynamic parameters (ΔS = 16.536 ± 0.397 J mol−1 K−1, ΔH = 560 ± 8.65 kJ mol−1 and ΔG = −27.916 ± 0.45 kJ mol−1 and) describes feasible, endothermic and spontaneous nature of adsorption. Regeneration studies demonstrated that the material is effective for up to six cycles. The material is very effective in real water samples. Computational results i.e. decrease in band gap (Eg = 1.735, 1.717 and 1.698 eV), EHOMO (−4.446, −4.677 and −4.431 eV), ELUMO (−2.710, −2.978 and −2.714 eV) and charge transfer phenomenon (Q = −0.2, −0.069 and −0.057) demonstrates hydrogen bonding and electrostatic interaction mechanisms. This study suggests that our prepared material can be used as a potential scavenger of emerging contaminants from water. [ABSTRACT FROM AUTHOR]

Stenotrophomonas maltophilia, a ubiquitous environmental bacterium, is an important cause of nosocomial infections. Although banned in some countries, paraquat (PQ) is commonly used to control weeds. In this study, we investigated the effects of increasing concentrations of PQ on S. maltophilia and its antimicrobial resistance. The sequential exposure of S. maltophilia K279a to increasing concentrations of PQ induces the formation of strains with increased resistance to PQ. Among the 400 PQ-resistant isolates tested, 70 clones were resistant to 16 μg/ml ciprofloxacin (CIP), and around 18% of the PQ/CIP-resistant isolates showed increased resistance to all the tested antimicrobials including, the aminoglycosides, quinolones, cephalosporin, chloramphenicol, and co-trimoxazole. The results of the expression analysis of the antimicrobial resistance genes in the five selected PQ/CIP-resistant isolates demonstrated the high expression of genes encoding efflux pumps (smeYZ, smaAB, smaCDEF, smeDEF, smeVWX, and smtcrA) and the enzymes aph(3')-IIc, blaL1, and blaL2. However, expression of the genes known for PQ resistance (i.e., mfsA and sod) were not altered relative to the wild-type levels. Whole genome sequence analysis identified gene mutations that could account for the antimicrobial resistance, namely, smeT (TetR family regulatory protein), rplA (ribosomal protein L1), and acnA (aconitase A). Ectopic expression of wild-type AcnA partially complemented the fluoroquinolone-resistant phenotype of the mutant with mutated acnA, which suggests the role of aconitase A in antimicrobial susceptibility. Exposure of S. maltophilia to PQ thus induces the development of strains that increase resistance to multiple antimicrobials. [ABSTRACT FROM AUTHOR]

The significance of this study lies in its exploration of bioactive plant extracts as a promising avenue for combating oral bacterial pathogens, offering a novel strategy for biofilm eradication that could potentially revolutionize oral health treatments. Oral bacterial infections are common in diabetic patients; however, due to the development of resistance, treatment options are limited. Considering the excellent antimicrobial properties of phenolic compounds, we investigated them against isolated oral pathogens using in silico and in vitro models. We performed antibiogram studies and minimum inhibitory concentration (MIC), antibiofilm, and antiquorum sensing activities covering phenolic compounds. Bacterial strains were isolated from female diabetic patients and identified by using 16S rRNA sequencing as Pseudomonas aeruginosa, Bacillus chungangensis, Bacillus paramycoides, and Paenibacillus dendritiformis. Antibiogram studies confirmed that all strains were resistant to most tested antibiotics except imipenem and ciprofloxacin. Molecular docking analysis revealed the significant interaction of rutin, quercetin, gallic acid, and catechin with transcription regulator genes 1RO5, 4B2O, and 5OE3. All tested molecules followed drug-likeness rules except rutin. The MIC values of the tested compounds varied from 0.0625 to 0.5 mg/mL against clinical isolates. Significant antibiofilm activity was recorded in the case of catechin (73.5% ± 1.6% inhibition against B. paramycoides), cinnamic acid (80.9% ± 1.1% inhibition against P. aeruginosa), and vanillic acid and quercetin (65.5% ± 1.7% and 87.4% ± 1.4% inhibition, respectively, against B. chungangensis) at 0.25-0.125 mg/mL. None of the phenolic compounds presented antiquorum sensing activity. It was, therefore, concluded that polyphenolic compounds may have the potential to be used against oral bacterial biofilms, and further detailed mechanistic investigations should be performed. [ABSTRACT FROM AUTHOR]

Ciprofloxacin (CIP) is the commonly prescribed fluoroquinolone antibiotic and one of the top ten emerging pharmaceutical contaminants in the world. It can pose a potential health risk if its residues enter the body. In this study, the adsorption of CIP onto magnetic iron oxide nanoparticles coated with silver (Fe3O4@AgNPs) was evaluated. Fe3O4@AgNPs were characterized by Fourier Transform Infrared Spectroscopy (FTIR), X‐ray Diffraction (XRD), and Scanning Electron Microscope (SEM). The parameters affecting the adsorption of CIP on nanoadsorbent were investigated including the adsorbent dose, pH, contact time, the salt content, and mixing speed. The highest efficiency of removal was achieved at pH 6, adsorbent dose of 3 mg l−1, salt content of 1 % (W/V) and shaking rate of 100 rpm. The adsorption process of CIP on the nanoadsorbent followed the Freundlich adsorption isotherm model, the adsorption kinetics was pseudo‐second order and the maximum adsorption capacity was 125 mg g−1. [ABSTRACT FROM AUTHOR]

Ciprofloxacin (CIP), a commonly used antibiotic, is frequently detected in water bodies and the natural environment. The profound health consequences of CIP have led to growing attention focusing on environmental concerns. Adsorption is highly preferred because of its adaptability and remarkable efficiency in removing CIP. Therefore, the current work focuses on synthesizing an eco-friendly and economical adsorbent for removing CIP. The work aims to remove CIP using zeolite X (ZX), synthesized from dolochar, and subsequently modified ZX into iron-modified zeolite X (FeZX) via ion exchange. The synthesized FeZX had a crystallinity of 82.701%, an average pore size of 5.917 nm, a micropore volume of 0.298 cc/g, a micropore area of 451.807 m2/g, and a total surface area of 478.521 m2/g. The effect of parameters such as initial CIP concentration, pH, contact period, adsorbent dosage, and iron dosage was analyzed in the batch adsorption studies of CIP using ZX and FeZX. CIP removal of 37.786% was achieved using ZX; hence, the adsorption parameters were optimized to maximize the CIP removal using response surface methodology (RSM), specifically Box-Behnken Design (BBD) using FeZX. Maximum removal of 97.974% was achieved under optimum conditions of 8.06 pH, contact period of 59.422 min, CIP concentration of 17.117 mg/L, and adsorbent dosage of 0.478 g/L. Freundlich isotherm and pseudo-second-order kinetic models were the most accurate representations of the experimental data. The findings indicate the significance of using this iron-modified mesoporous zeolite as an adsorbent for efficiently treating CIP wastewater. [ABSTRACT FROM AUTHOR]

This study reports the photoelectrocatalytic (PEC) activity of a n–n heterojunction comprising MoS2 and NiSe2. The synthesis of the composite was achieved through a facile solvothermal method, yielding an exfoliated MoS2 layered sheet loaded with NiSe2 nanoparticles. Under visible light radiation and an external electric field, the obtained composite NiSe2/MoS2 exhibited enhanced catalytic activity for ciprofloxacin (CIP) degradation. The NiSe2/MoS2 heterojunction achieved about 78 % degradation efficiency with a first‐order kinetic rate of 0.0111 min−1, compared to 38 % efficiency and a first‐order kinetic rate of 0.0044 min−1 observed for MoS2. The NiSe2/MoS2 heterojunction was more advantageous due to the synergy of charge carrier induction by visible light radiation and improved charge carrier separation induced by the external electric field. The formation of n–n heterojunction at the interface of the two materials resulted in charge redistribution in the materials, with a simultaneous realignment of the band structure to achieve Fermi energy equilibration. The primary reactive species responsible for CIP degradation was identified as the photo‐induced h+. Furthermore, the catalyst exhibited high stability and reusability, with no significant reduction in activity observed after five experimental cycles. This study reveals the potential of exploring the synergy between the photocatalytic and electrocatalytic processes in removing harmful pharmaceutical compounds from water. [ABSTRACT FROM AUTHOR]

ABSTRACT The objective of this study was to determine the pharmacokinetics of enrofloxacin and its metabolite, ciprofloxacin, in Nanyang cattle after a single intravenous (IV), and intramuscular (IM) administration of enrofloxacin at 2.5 mg/kg body weight (BW). Blood samples were collected at predetermined time points. Enrofloxacin and ciprofloxacin concentrations in plasma were simultaneously determined using a high‐performance liquid chromatography (HPLC) assay method and subjected to a non‐compartmental analysis. After IV administration, enrofloxacin had a mean (±SD) volume of distribution at steady state (VSS) of 1.394 ± 0.349 L/kg, a terminal half‐life (t1/2λz) of 3.592 ± 1.205 h, and a total body clearance (Cl) of 0.675 ± 0.16 L/h/kg. After IM administration, enrofloxacin was absorbed relatively slowly but completely, with a mean absorption time (MAT) of 6.051 ± 1.107 h and a bioavailability of 99.225 ± 7.389%. Both compounds were detected simultaneously in most plasma samples following both routes of administration, indicating efficient biotransformation of enrofloxacin to ciprofloxacin. After IV injection, the peak concentration (Cmax) of ciprofloxacin was 0.315 ± 0.017 μg/mL, observed at 0.958 ± 0.102 h. Following IM injection, the corresponding values were 0.071 ± 0.006 μg/mL and 3 ± 1.095 h, respectively. Following IV and IM administration, the conversion ratio of enrofloxacin to ciprofloxacin was calculated as 59.2 ± 9.6% and 31.2 ± 7.7%, respectively. The present results demonstrated favorable pharmacokinetic profiles for enrofloxacin, characterized by complete absorption with relatively slow kinetics, extensive distribution, efficient biotransformation to ciprofloxacin, and prolonged elimination in Nanyang cattle. [ABSTRACT FROM AUTHOR]

Simple Summary: The widespread use of antibiotics in poultry production has raised public concerns about food safety and meat quality. This study investigated the effects of early ciprofloxacin use on Xueshan chickens, focusing on growth, meat quality, and metabolic changes. It was found that, while ciprofloxacin treatment did not affect overall chicken growth, it significantly altered meat quality characteristics, which may affect meat texture and preservability. Although ciprofloxacin residues were not detected in muscle, metabolic analyses revealed significant metabolic alterations, particularly in microbial and amino acid metabolism pathways. These findings emphasize that antibiotic use may have far-reaching effects on poultry product quality, involving not only direct meat quality changes but also complex metabolic reactions. This study provides new perspectives for understanding the role of antibiotics in poultry production, which is important for optimizing antibiotic-use strategies and ensuring food safety. The results may be an important reference for poultry producers, food safety regulators and consumers. To investigate the effects of early administration of ciprofloxacin (CIP) on Xueshan chickens, in this study Xueshan chickens were measured for growth performance, tested for drug residues, evaluated for meat quality, and muscle metabolism changes were explored using a non-target metabolomics approach. Experimental findings revealed that early CIP use did not significantly impact the overall growth rate of Xueshan chickens (p > 0.05). However, notable alterations in meat quality were observed: the CIP-treated group exhibited a significant decrease in muscle pH (pH1 and pH24) and a marked increase in drip loss and moisture content (p > 0.05). No CIP residues were detected in muscle tissue. Untargeted metabolomics analyses unveiled significant alterations in the metabolic profile of market-age chickens following CIP treatment. Both functional enrichment and metabolic network analyses indicated significant effects on the ko01120 (microbial metabolism in diverse environments) and ko00350 (tyrosine metabolism) pathways, implying that CIP treatment may influence chicken meat quality by modulating microbial communities and amino acid metabolism. This study provides a crucial foundation for understanding the impact of antibiotics on meat quality and metabolism in poultry production, offering scientific insights for optimizing antibiotic-use strategies and safeguarding poultry product quality. [ABSTRACT FROM AUTHOR]

The rise of antibiotic tolerance in bacteria harboring genetic elements conferring resistance to antibiotics poses an increasing threat to public health. However, the primary factors responsible for the emergence of antibiotic tolerance and the fundamental molecular mechanisms involved remain poorly comprehended. Here, we demonstrate that the commonly utilized food additive Benzaldehyde (BZH) possesses the capacity to induce a significant level of fluoroquinolone tolerance in vitro among resistant Escherichia coli. Our findings from animal models reveal that the pre-administration of BZH results in an ineffective eradication of bacteria through ciprofloxacin treatment, leading to similar survival rates and bacterial loads as observed in the control group. These results strongly indicate that BZH elicits in vivo tolerance. Mechanistic investigations reveal several key factors: BZH inhibits the formation of bacterial flagella and releases proton motive force (PMF), which aids in expelling antibiotics from within cells to reducing their accumulation inside. In addition, BZH suppresses bacterial respiration and inhibits the production of reactive oxygen species (ROS). Moreover, exogenous pyruvate successfully reverses BZH-induced tolerance and restores the effectiveness of antibiotics, highlighting how crucial the pyruvate cycle is in combating antibiotic tolerance. The present findings elucidate the underlying mechanisms of BZH-induced tolerance and highlight potential hazards associated with the utilization of BZH. [ABSTRACT FROM AUTHOR]

The present work reports the facile synthesis and characterization of a series of diverse 2′-oxo-6b,7,8,9-tetrahydro-6H-spiro[chromeno[3,4-a]pyrrolizine-11,3′-indoline]-6a(11aH)-carbaldehyde derivatives following 1,3-dipolar cycloaddition reaction. This one-pot three-component synthesis involves 2H-chromene-3-carbaldehyde, isatin and secondary amino acids (L -proline/pipecolinic acid) in ethanol to produce the corresponding cycloadducts by conventional and microwave irradiation methods. To determine the regio and stereoselectivity of the product and investigate the mechanism, density functional theory (DFT) studies were done along with 1H, 13C-NMR, DEPT, COSY, NOESY and HRMS. The cycloaddition is found to proceed via four different closely lying transition states as predicted by DFT studies and thermochemical analysis. Furthermore, natural bond orbital (NBO) analysis has been employed to confirm that the cycloaddition follows a radical mechanism. The reaction was found to undergo meta-regioselectivity/endo-stereoselectivity via the most favoured pathway. The synthesized compounds were assessed for in vitro antibacterial activity against Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria, using ciprofloxacin as the standard. Compound 16a demonstrated significant inhibitory effects on E. coli and S. aureus, with a zone of inhibition (ZI) of 17 mm and a minimum inhibitory concentration (MIC) of 6.25 μg mL−1 for each of the strains. Additionally, an in silico docking study was conducted to look into the active binding mode of the synthesized compounds within the target enzyme. Structural analysis and molecular docking revealed enhanced binding to bacterial DNA gyrase (E. coli: PDB ID: 1KZN , S. aureus: PDB ID: 3G7B) with a binding affinity of −8.3 kcal mol−1 for compound 16a. In silico ADME predictions suggested favorable pharmacokinetic properties, indicating the potential of these compounds as oral antibacterial drug candidates. [ABSTRACT FROM AUTHOR]

Pure water scarcity is the most significant emerging challenge of the modern society. Various organics such as pesticides (clomazone, quinmerac), pharmaceuticals (ciprofloxacin, 17α-ethynilestradiol), and mycotoxins (deoxynivalenol) can be found in the aquatic environment. The aim of this study was to fabricate ZnO nanomaterial on the basis of banana peel extract (ZnO/BPE) and investigate its efficiency in the photocatalytic degradation of selected organics under various experimental conditions. Newly synthesized ZnO/BPE nanomaterials were fully characterized by the XRD, FTIR, SEM-EPS, XPS, and BET techniques, which confirmed the successful formation of ZnO nanomaterials. The photocatalytic experiments showed that the optimal catalyst loading of ZnO/BPE was 0.5 mg/cm3, while the initial pH did not influence the degradation efficiency. The reusability of the ZnO/BPE nanomaterial was also tested, and minimal activity loss was found after three photocatalytic cycles. The photocatalytic efficiency of pure banana peel extract (BPE) was also studied, and the obtained data showed high removal of ciprofloxacin and 17α-ethynilestradiol. Finally, the influence of water from Danube River was also examined based on the degradation efficiency of selected pollutants. These results showed an enhanced removal of ciprofloxacin in water from the Danube River, while in the case of other pollutants, the treatment was less effective. [ABSTRACT FROM AUTHOR]

In this study, a magnetic porous polymer composite with both hydrophilic and hydrophobic groups was synthesized for magnetic solid phase extraction (MSPE) of milk substrates. Optimization was conducted on various parameters, including adsorption dose, solution pH, adsorption time, and some elution conditions. Coupled with a high-performance liquid chromatography fluorescence detector, a novel MSPE method for determination of norfloxacin (NFX), ciprofloxacin (CIP), and enrofloxacin (ENR) in milk was developed based on magnetic metal organic framework polystyrene polymer (Fe3O4@MOF@PLS) as adsorbent. The Fe3O4@MOF@PLS exhibited significantly improved adsorption performance compared to MOF and PLS. Under optimized experimental conditions, the method exhibited good linearity for the three fluoroquinolones (FQs) in the range of 0.5–1000 μg/kg, with limit of detections (LODs) ranging from 0.21 to 1.33 μg/kg, and limit of quantitations (LOQs) from 0.71 to 4.42 μg/kg. The relative standard deviation (RSD) for the three FQs were 3.4–8.8%. The recoveries of three FQs in milk samples ranged from 84.2% to 106.2%. This method was successfully applied to the detection of three FQs in 20 types of milk, demonstrating its simplicity, speed, and effectiveness in analyte enrichment and separation. The method presented advantages in adsorbent dosage, adsorption time, LODs, and LOQs, making it valuable for the analysis and detection of FQs in milk. [ABSTRACT FROM AUTHOR]

Antibiotic residues in water environments have garnered widespread attention. Metal-organic frameworks (MOFs) have found extensive applications in water purification. This study investigates the use of a cobalt-based MOF material, zeolitic imidazolate framework-67(ZIF-67)(Co), for activating persulfate (PMS) to remove residual antibiotic ciprofloxacin (CIP) from aqueous environments. The main findings are as follows: ZIF-67(Co) exhibits insignificant adsorption capacity for CIP, and PMS alone does not degrade CIP effectively. However, ZIF-67(Co)-activated PMS demonstrates the efficient degradation of CIP, following pseudo-second-order reaction kinetics. Under optimal conditions of the catalyst dosage (15 mg) and PMS concentration (1.0 mM), the removal efficiency reaches 88% after 60 min. Comparative analysis of CIP degradation at different initial pH levels shows that the highest efficiency is reached under mildly acidic conditions, with an 86% removal rate achieved within 60 min under these conditions. Investigation into the impact of various inorganic anions on the ZIF-67(Co)-catalyzed PMS degradation of CIP reveals significant inhibition by chloride ions ( Cl − ), whereas nitrate ( NO 3 - ) and sulfate ( SO 4 2 - ) ions have minor effects on the degradation efficiency. The system demonstrates a consistent performance across different water matrices, highlighting ZIF-67(Co)/PMS as effective for ciprofloxacin removal in environmental waters. This study provides technical support for the efficient removal of antibiotic residues. [ABSTRACT FROM AUTHOR]